Walleye Capital’s Medline MDLN Stock Holding History
Bought
Maintained
Sold
Other funds holding MDLN
Walleye Capital's MDLN Position: Q3 2026 in Review
Walleye Capital increased its Medline (MDLN) stake by 4,974% in Q3 2026, buying an estimated $16.1M and bringing the position to 448,937 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #929.
Walleye Capital first reported a position in MDLN in Q4 2025 and has held it in 4 quarters since. The position peaked at $18M in Q1 2026. 412 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.
- Walleye Capital held 448,937 shares of Medline worth $15.6M as of Q3 2026.
- Walleye Capital bought 440,089 Medline shares in Q3 2026, an estimated $16.1M.
- Medline made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #929 holding.
- Walleye Capital first reported a position in Medline in Q4 2025 and has held it in 4 quarters since.
- Walleye Capital's Medline position peaked at $18M in Q1 2026.
- 412 funds tracked by Wall St. Rank held Medline as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.